tolvaptan has been researched along with p-aminohippuric acid in 2 studies
| Studies (tolvaptan) | Trials (tolvaptan) | Recent Studies (post-2010) (tolvaptan) | Studies (p-aminohippuric acid) | Trials (p-aminohippuric acid) | Recent Studies (post-2010) (p-aminohippuric acid) |
|---|---|---|---|---|---|
| 967 | 172 | 786 | 2,231 | 64 | 88 |
| Protein | Taxonomy | tolvaptan (IC50) | p-aminohippuric acid (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 6 | Homo sapiens (human) | 8.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Czerwiec, FS; Glockner, J; Hogan, MC; Irazabal, MV; King, BF; Krasa, HB; Ofstie, TG; Ouyang, J; Torres, VE | 1 |
1 review(s) available for tolvaptan and p-aminohippuric acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for tolvaptan and p-aminohippuric acid
| Article | Year |
|---|---|
Short-term effects of tolvaptan on renal function and volume in patients with autosomal dominant polycystic kidney disease.
Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Biomarkers; Contrast Media; Creatinine; Diuresis; Female; Glomerular Filtration Rate; Hormone Antagonists; Humans; Iothalamic Acid; Kidney; Magnetic Resonance Imaging; Male; Middle Aged; Minnesota; Organ Size; p-Aminohippuric Acid; Polycystic Kidney, Autosomal Dominant; Potassium; Receptors, Vasopressin; Renal Circulation; Time Factors; Tolvaptan; Treatment Outcome; Uric Acid | 2011 |